Companies / Australia
Macular Degeneration On The Rise
October 2006 | Industry NewsAustralia's ageing population is causing a substantial rise in cases of macular degeneration (MD) with the government expected to foot most of the bill. MD occurs when the macular - which is the part of the eye responsible for central vision and seeing fine detail - breaks down, making it hard for the sufferer to see small objects. It is estimated that MD costs the federal government AUD2.6bn (US$2bn) per year, although this figure is expected to rise to AUD6.5bn (US$4.99bn) by 2025.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
